z-logo
open-access-imgOpen Access
Does High‐Dose Prophylactic Acyclovir Add Benefit in Allogeneic Marrow Transplant Recipients Receiving Prophylactic or Preemptive Ganciclovir?
Author(s) -
Rafael de la Cámara,
J M Fernández-Rañada
Publication year - 1999
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/314892
Subject(s) - ganciclovir , medicine , prophylactic treatment , aciclovir , immunology , virology , herpesviridae , surgery , viral disease , virus , human cytomegalovirus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom